Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariaemma Rodegher

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Neuroscience Letters|November 24, 2011
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkersFilippo Martinelli-Boneschi, Chiara Fenoglio, Paola Brambilla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 29, 2017
Dysregulation of MS risk genes and pathways at distinct stages of diseaseSundararajan Srinivasan, Marco Di Dario, Alessandra Russo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational studyChiara Zecca, Arianna Merlini, Giulio Disanto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2012
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in ItalyPietro Annovazzi, Valentina Tomassini, Benedetta Bodini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2012
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndromeGiancarlo Comi, Vittorio Martinelli, Mariaemma Rodegher, et al.
Neuroscience Letters|October 17, 2012
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern EuropeansPaola Brambilla, Federica Esposito, Eva Lindstrom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2012
A genome-wide association study in progressive multiple sclerosisFilippo Martinelli-Boneschi, Federica Esposito, Paola Brambilla, et al.
Annals of Neurology|April 28, 2015
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activityFederica Esposito, Melissa Sorosina, Linda Ottoboni, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Brain : a Journal of Neurology|September 13, 2015
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosisPietro Iaffaldano, Giuseppe Lucisano, Carlo Pozzilli, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Neuroscience Letters|November 24, 2011
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkersFilippo Martinelli-Boneschi, Chiara Fenoglio, Paola Brambilla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 29, 2017
Dysregulation of MS risk genes and pathways at distinct stages of diseaseSundararajan Srinivasan, Marco Di Dario, Alessandra Russo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational studyChiara Zecca, Arianna Merlini, Giulio Disanto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2012
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in ItalyPietro Annovazzi, Valentina Tomassini, Benedetta Bodini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2012
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndromeGiancarlo Comi, Vittorio Martinelli, Mariaemma Rodegher, et al.
Neuroscience Letters|October 17, 2012
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern EuropeansPaola Brambilla, Federica Esposito, Eva Lindstrom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2012
A genome-wide association study in progressive multiple sclerosisFilippo Martinelli-Boneschi, Federica Esposito, Paola Brambilla, et al.
Annals of Neurology|April 28, 2015
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activityFederica Esposito, Melissa Sorosina, Linda Ottoboni, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Brain : a Journal of Neurology|September 13, 2015
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosisPietro Iaffaldano, Giuseppe Lucisano, Carlo Pozzilli, et al.
Pageof 6